SRL
ACAD icon

Scientech Research LLC’s Acadia Pharmaceuticals ACAD Stock Holding History

Scientech Research LLC’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37,558
Closed -$801K – 484
2025
Q3 		$801K Buy
+37,558
New +$888K 0.28% 84
2025
Q2 		– Sell
-37,785
Closed -$628K – 574
2025
Q1 		$628K Buy
37,785
+27,384
+263% +$497K 0.17% 276
2024
Q4 		$191K Buy
+10,401
New +$168K 0.05% 498
2024
Q3 		– Sell
-41,586
Closed -$676K – 593
2024
Q2 		$676K Buy
+41,586
New +$671K 0.14% 257

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Scientech Research LLC's ACAD Position: Q4 2025 in Review

Scientech Research LLC sold out of Acadia Pharmaceuticals (ACAD) in Q4 2025, closing a stake of 37,558 shares — an estimated $801K sold.

Scientech Research LLC first reported a position in ACAD in Q2 2024 and held it in 4 quarters. The position peaked at $801K in Q3 2025. 336 funds tracked by Wall St. Rank hold ACAD as of Q4 2025.

  • Scientech Research LLC reported no remaining Acadia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 37,558 Acadia Pharmaceuticals shares in Q4 2025, an estimated $801K.
  • Scientech Research LLC first reported a position in Acadia Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Scientech Research LLC's Acadia Pharmaceuticals position peaked at $801K in Q3 2025.
  • 336 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.